Literature DB >> 35992254

Renal tubular injury in hyperbilirubinemia: Bile cast nephropathy.

Xun Zhao1, Ruiyao Huang1, Philip Wong1, Pierre-Oliver Fiset2, Marc Deschênes1.   

Abstract

The toxic renal accumulation of bile pigment sparked clinical intrigue almost a century ago. More recently, however, the identification of bile casts within renal tubules in patients with liver dysfunction has been largely overlooked. We have reviewed the literature, including natural history, pathophysiology, and potential treatment of bile cast nephropathy (BCN). We report two cases of acute kidney injury (AKI) associated with acute-on-chronic liver failure in which prolonged hyperbilirubinemia and bile cast identification on renal biopsy evoked the diagnosis of BCN.
Copyright © 2021 Canadian Association for the Study of the Liver.

Entities:  

Keywords:  bile casts; cirrhosis; hepatorenal syndrome; nephropathy; transplant

Year:  2021        PMID: 35992254      PMCID: PMC9202769          DOI: 10.3138/canlivj-2020-0031

Source DB:  PubMed          Journal:  Can Liver J        ISSN: 2561-4444


  18 in total

1.  Bile cast nephropathy.

Authors:  Koyal Jain; Akanksha Gupta; Harsharan K Singh; Volker Nickeleit; Abhijit V Kshirsagar
Journal:  Kidney Int       Date:  2015-02       Impact factor: 10.612

2.  Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction.

Authors:  Charles M van Slambrouck; Fadi Salem; Shane M Meehan; Anthony Chang
Journal:  Kidney Int       Date:  2013-03-13       Impact factor: 10.612

Review 3.  Bile cast nephropathy: A case report and review of the literature.

Authors:  Jaymon Patel; Saqib Walayat; Nikhil Kalva; Sidney Palmer-Hill; Sonu Dhillon
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

4.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Authors:  Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

5.  Bile Cast Nephropathy in Cirrhotic Patients: Effects of Chronic Hyperbilirubinemia.

Authors:  Michelle Foshat; Heather M Ruff; Wayne G Fischer; Robert E Beach; Mark R Fowler; Hyunsu Ju; Judith F Aronson; Marjan Afrouzian
Journal:  Am J Clin Pathol       Date:  2017-05-01       Impact factor: 2.493

6.  A case of mononucleosis infectiosa presenting with cholemic nephrosis.

Authors:  Obbo W Bredewold; Johan W de Fijter; Ton Rabelink
Journal:  NDT Plus       Date:  2011-04-14

7.  Bile Cast Nephropathy: A Pathologic Finding with Manifold Causes Displayed in an Adult with Alcoholic Steatohepatitis and in a Child with Wilson's Disease.

Authors:  Jose Torrealba; Nathan T Sweed; Daniel Burguete; Allen R Hendricks
Journal:  Case Rep Nephrol Dial       Date:  2018-09-27

8.  Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice.

Authors:  Peter Fickert; Elisabeth Krones; Marion J Pollheimer; Andrea Thueringer; Tarek Moustafa; Dagmar Silbert; Emina Halilbasic; Min Yang; Hartmut Jaeschke; Geurt Stokman; Rebecca G Wells; Kathrin Eller; Alexander R Rosenkranz; Gosta Eggertsen; Carsten A Wagner; Cord Langner; Helmut Denk; Michael Trauner
Journal:  Hepatology       Date:  2013-10-15       Impact factor: 17.425

9.  Severe Cholestasis and Bile Acid Nephropathy From Anabolic Steroids Successfully Treated With Plasmapheresis.

Authors:  Avegail Flores; Rosemary Nustas; Hoang-Lan Nguyen; Robert S Rahimi
Journal:  ACG Case Rep J       Date:  2016-01-20

10.  Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure.

Authors:  Cornelius Engelmann; Karen Louise Thomsen; Nekisa Zakeri; Mohammed Sheikh; Banwari Agarwal; Rajiv Jalan; Rajeshwar P Mookerjee
Journal:  Crit Care       Date:  2018-10-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.